Screener
Palvella Therapeutics PVLA Operating Lease Liabilities (Current)
Operating Lease Liabilities (Current) at other companies
Other financials
Where this comes from
Reported directly by Palvella Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseLiabilityCurrent.
The source filing: Palvella Therapeutics’s 10-Q, filed May 7, 2026.
- Filed
- May 7, 2026, 8:30 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-210463
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Current liabilities: | ||
| Accounts payable | $5,443 | $4,595 |
| Derivative liabilities – contingent value right liability | — | 2,196 |
| Current portion of operating lease liability | 209 | 202 |
| Accrued expenses and other current liabilities | 3,463 | 4,351 |
| Total current liabilities | 9,115 | 11,344 |
| Long-term portion of operating lease liability | 375 | 431 |
| Royalty agreement liability | 19,799 | 17,760 |
Item 1. Financial Statements.
FAQ
- What is Palvella Therapeutics's operating lease liabilities (current)?
- Palvella Therapeutics (PVLA) reported operating lease liabilities (current) of $209K in Q1 2026.
- What is the long-term trend for Palvella Therapeutics's operating lease liabilities (current)?
- Over 5 years (2020 to 2025), Palvella Therapeutics's operating lease liabilities (current) has grown at a -27.8% compound annual growth rate (CAGR), from $1.03M to $202K.
- What does operating lease liabilities (current) mean?
- The current portion of operating lease obligations due within one year, representing committed future lease payments under ASC 842.
Ask your AI about Palvella Therapeutics's operating lease liabilities (current).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude